Trial intelligence / Profile preview

PfSPZ Challenge in Adults with Malaria Exposure and Sickle Cell Trait

NCT02237586Phase 1Completed

Sponsor
Sanaria Inc.
Start
Jul 2014
Primary completion
Sep 2014
Modality
Live Biotherapeutic Products, Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 1, triple-blind trial of PfSPZ Challenge in malaria, sponsored by Sanaria Inc. Started Jul 2014; status: completed.

02

Drugs

PfSPZ Challenge
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02237586.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02237586.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call